✦ LIBER ✦

Safety and efficacy of a new regimen of intravenous recombinant tissue-type plasminogen activator potentially suitable for either prehospital or in-hospital administration

✍ Scribed by George R. McKendall; Michael J. Attubato; Thomas M. Drew; Frederick Feit; Barry L. Sharaf; Edward S. Thomas; Sam Teichman; Mary Jane McDonald; David O. Williams

Book ID: 119167991
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 301 KB
Volume: 18
Category: Article
ISSN: 1558-3597
DOI: 10.1016/0735-1097(91)90520-j

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of a Modified Intrav

Efficacy and Safety of a Modified Intravenous Recombinant Tissue Plasminogen Activator Regimen in Chinese Patients with Acute Ischemic Stroke

✍ Pan, Shu-Ming; Liu, Jia-Fu; Liu, Ming; Shen, Sa; Li, Hao-Jun; Dai, Li-Hua; Chen, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 184 KB

The safety and efficacy of the intraveno

The safety and efficacy of the intravenous recombinant tissue plasminogen activator for the ischemic stroke patients in community based hospital

✍ Joung, J.; Song, I.U.; Joung, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: a comparison of three dosing regimens

✍ Stephen Eppler; Taurence Senn; Ellen Gilkerson; Nishit B. Modi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

Recombinant tissue-type plasminogen activator (rt-PA) is indicated for the treatment of acute myocardial infarction as a dose of up to 100 mg. Several clinical trials have suggested that higher patency rates can be achieved with a rapid drug administration. A study was conducted in rabbits to determ